The key effector pathway of Wnt signaling (β-cat/TCF7L2) has beenrecently implicated in metabolic homoeostasis, diabetes, obesity, osteoporosis,cardiovascular disease, and cancer [9,22-24]. Here, TCF7L2 is linked to cardiovascular disorder.